Volume 387, Issue 10034, Pages 2218-2225 (May 2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis  Dr Prof Vinod H Thourani, MD, Susheel Kodali, MD, Raj R Makkar, MD, Prof Howard C Herrmann, MD, Mathew Williams, MD, Vasilis Babaliaros, MD, Prof Richard Smalling, MD, Scott Lim, MD, S Chris Malaisrie, MD, Prof Samir Kapadia, MD, Wilson Y Szeto, MD, Kevin L Greason, MD, Prof Dean Kereiakes, MD, Gorav Ailawadi, MD, Brian K Whisenant, MD, Chandan Devireddy, MD, Jonathon Leipsic, MD, Rebecca T Hahn, MD, Prof Philippe Pibarot, PhD, Prof Neil J Weissman, MD, Wael A Jaber, MD, Prof David J Cohen, MD, Rakesh Suri, MD, Prof E Murat Tuzcu, MD, Prof Lars G Svensson, MD, Prof John G Webb, MD, Prof Jeffrey W Moses, MD, Prof Michael J Mack, MD, Prof D Craig Miller, MD, Prof Craig R Smith, MD, Maria C Alu, MM, Rupa Parvataneni, MS, Prof Ralph B D'Agostino, PhD, Prof Martin B Leon, MD  The Lancet  Volume 387, Issue 10034, Pages 2218-2225 (May 2016) DOI: 10.1016/S0140-6736(16)30073-3 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 Study profile TAVR=transcatheter aortic valve replacement. BAV=balloon aortic valvuloplasty. TEE=transoesophageal echocardiogram. The Lancet 2016 387, 2218-2225DOI: (10.1016/S0140-6736(16)30073-3) Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 2 All-cause mortality stratified by severity of paravalvular aortic regurgitation after transcatheter aortic valve replacement Patients were classified into groups based on their 30 day echocardiogram (or discharge echocardiogram if 30 day was not available). The Lancet 2016 387, 2218-2225DOI: (10.1016/S0140-6736(16)30073-3) Copyright © 2016 Elsevier Ltd Terms and Conditions